The effects of leupeptin on cochlear blood flow, auditory sensitivity, and histology

International Tinnitus Journal

Volumn 7, Issue 1, 2001, Pages 4-12

  Tang, Wenxue ^a   Seidman, Michael D ^a   Henig, Joseph P ^a   Shulman, Abraham ^a   Stracher, Alfred ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Auditory brainstem response; Cochlear blood flow; Cytocochleograms; Leupeptin; Neuroprotection

Indexed keywords

CALPAIN; LEUPEPTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY BRAINSTEM RESPONSE; AUDITORY RESPONSE; AUDITORY THRESHOLD; COCHLEA; COCHLEA BLOOD FLOW; COCHLEA FENESTRA; CONTROLLED STUDY; CORTI ORGAN; DRUG SAFETY; ELECTROCOCHLEOGRAPHY; GUINEA PIG; HAIR CELL; HEARING LOSS; MALE; MEAN ARTERIAL PRESSURE; NEUROPROTECTION; NOISE INJURY; NONHUMAN; OSMOTIC PUMP; OXIDATIVE STRESS; PRIORITY JOURNAL; TINNITUS;

ANIMALS; CALPAIN; COCHLEA; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GUINEA PIGS; HEARING LOSS, NOISE-INDUCED; LEUPEPTINS; MALE; NEUROPROTECTIVE AGENTS; PROTEASE INHIBITORS; RANDOM ALLOCATION; REGIONAL BLOOD FLOW; TINNITUS;

EID: 0035688672     PISSN: 09465448     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Calcium activated neutral proteases (milli- and micro-CANP) and endogenous CANP inhibitor of muscle in Duchenne muscular dystrophy (DMD)
2. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: A potential molecular basis for neuronal degeneration
3. Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia
4. A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain
5. 2+ is mediated by the activation of a non-lysosomal proteolytic system
6. pH-dependent nonlysosomal proteolysis contributes to lethal anoxic injury of rat hepatocytes
7. Inhibition of nonlysosomal calcium-dependent proteolysis by glycine during anoxic injury of rat hepatocytes
8. 2+ and proteolysis in lethal oxidative injury in endothelial cells
9. Comparison of cell-permeable calpain inhibitors and E64 in reduction of cataract in cultured rat lenses
10. Roles of calpain in hypoxic-ischemic neuronal injury
11. Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat
12. Neuromuscular recovery using calcium protease inhibition after median nerve repair in primates
13. Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra-arterial administration
14. Neuromuscular recovery after peripheral nerve repair: Effects of an orally administered peptide in a primate model
15. Update on tinnitus
16. Calpain inhibitors as neuroprotective agents in neurodegenerative disorders
17. Neuroprotective drug therapy: A medical and pharmacological treatment for tinnitus control
18. Protecting the inner ear from acoustic trauma
19. Leupeptin protects sensory hair cells from acoustic trauma
20. Cochlear frequency-position function for several species - 29 Years later
21. The accuracy of hair cell counts in determining distance and position along the organ of Corti
22. Mechanisms of calpain proteolysis following traumatic brain injury: Implications for pathology and therapy. A review and update
23. Calpain: Novel family members, activation, and physiologic function
24. New era of calpain research. Discovery of tissue-specific calpains
25. Upregulation of calpain activity and expression in experimental allergic encephalomyelitis: A putative role for calpain in demyelination
26. Calpain activation in apoptosis
27. Nilvadipine attenuates ischemic degradation of gerbil brain cytoskeletal proteins
28. Calcium-activated neutral protease (CANP) in brain and other tissues
29. Role of calpain and its inhibitors in tissue degeneration and neuroprotection in spinal cord injury
30. Role of calpain in spinal cord injury: Effects of calpain and free radical inhibitors
31. Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis
32. Expression of calpain I messenger RNA in human renal cell carcinoma: Correlation with lymph node metastasis and histological type
33. Proteases, proteolysis, and apoptosis
34. Novel pharmacologic strategies in the treatment of experimental traumatic brain injury: 1998
35. Activation of the neutral cysteine protease, calpain, during cochlear injury
36. Activation of calpain in the cochlea following noise exposure
37. Calpain inhibitors protect auditory sensory cells from hypoxia and neurotrophin withdrawal-induced apoptosis